During the past decade, Sina Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sina Hospital" are "Fatty Liver" (2 trials), "Non-alcoholic Fatty Liver Disease" (2 trials), "Appendicitis" (1 trials), "Endotracheal Intubation" (1 trials) and "HER2-positive Breast Cancer" (1 trials). Many other conditions were trialed in "Sina Hospital" in a lesser frequency.

Most popular intervention types in "Sina Hospital" are "Drug" (11 trials), "Behavioral" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "H.pylori eradication" (2 trials), "placebo" (2 trials), "Bevacizumab + FOLFIRI-3" (1 trials), "Bonfils" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sina Hospital" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sina Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Sina Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sina Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".